Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of novel biological medicine for improving fungal infection healing efficiency

A technology for fungal infection and new organisms, applied in the directions of medical preparations, pharmaceutical formulations, antifungal agents, etc. containing active ingredients, which can solve the problems of long treatment process, recurrence, and difficulty in achieving the effect of curing, and achieves difficult recurrence. , improve the effect, improve the effect of healing efficiency

Inactive Publication Date: 2020-08-11
吴红荣
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there are many kinds of treatment methods for fungal infections, and there are many kinds of therapeutic drugs. Although many external plasters in the prior art can play a certain therapeutic effect, the treatment process is relatively long, and there will be more after treatment. There are few relapses, it is difficult to achieve the effect of cure, and there are certain limitations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] The embodiment of the present invention provides a method for preparing a new biomedicine that improves the healing efficiency of fungal infection. The new biomedicine is composed of a pharmaceutical composition A, a pharmaceutical composition B and an additive composition C. The pharmaceutical composition A, the pharmaceutical composition B and the pharmaceutical composition The mass fraction ratio of the added composition C is 12:7:1;

[0032] Pharmaceutical composition A includes the following raw materials in parts by weight: 10 parts of miconazole nitrate, 8 parts of itraconazole, 4 parts of triamcinolone acetonide acetate, 6 parts of clobetasol propionate and 1 part of compound tincture of benzoic acid;

[0033] The pharmaceutical composition B includes the following raw materials in parts by weight: 4-6 parts of Herba Cnidii, 10 parts of Cnidium, 8 parts of Kochia, 7 parts of Raw Burnet, 5 parts of Artemisia, 3 parts of Aloe, 4 parts of Honeysuckle and 2 parts of ...

Embodiment 2

[0047] An embodiment of the present invention provides a method for preparing a new biomedicine that improves the healing efficiency of fungal infections. The new biomedicine consists of a pharmaceutical composition A, a pharmaceutical composition B, and an additional composition C. The pharmaceutical composition A, the pharmaceutical composition B, and The mass fraction ratio of the added composition C is 12:7:1;

[0048] Pharmaceutical composition A includes the following raw materials in parts by weight: 11 parts of miconazole nitrate, 9 parts of itraconazole, 5 parts of triamcinolone acetonide acetate, 7 parts of clobetasol propionate and 2 parts of compound tincture of benzoic acid;

[0049]The pharmaceutical composition B includes the following raw materials in parts by weight: 5 parts of Herba Cnidii, 11 parts of Cnidium, 10 parts of Kochia, 8 parts of Raw Burnet, 5.5 parts of Artemisia Artemisiae, 4 parts of Aloe Vera, 5 parts of Honeysuckle and 3 parts of Cypress Fruit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation method of a novel biological medicine for improving fungal infection healing efficiency, and relates to the technical field of fungal infection treatment. The novel biological medicine is composed of a pharmaceutical composition A, a pharmaceutical composition B and an additive composition C, wherein the mass fraction ratio of the pharmaceutical composition A to the pharmaceutical composition B to the additive composition C is 12:7:1. The pharmaceutical composition A comprises miconazole nitrate, itraconazole, triamcinolone acetonide acetate, clobetasol propionate and compound benzoic acid tincture; and the pharmaceutical composition B comprises cotton grass, fructus cnidii, fructus kochiae, radix sanguisorbae, artemisia argyi, aloe, honeysuckle flowersand cypress fruits. According to the invention, through the cooperation of the pharmaceutical composition A, the pharmaceutical composition B and the additive composition C, the prepared product canbe externally applied to effectively treat fungal patients, so that the fungal infection treatment effect is greatly improved, the fungal infection healing efficiency is also improved, and the patients are not easy to relapse after being healed.

Description

technical field [0001] The invention relates to the technical field of fungal infection treatment, in particular to a new biomedicine preparation method for improving the healing efficiency of fungal infection. Background technique [0002] Fungi are a kind of eukaryotic organisms. The most common fungi are all kinds of mushrooms. In addition, fungi also include molds and yeasts. More than 70,000 kinds of fungi have been discovered, which is estimated to be only a small half of all existing fungi. Most fungi were originally divided into Animals or plants; currently, fungi have been classified as separate kingdoms in taxonomy, paralleling the kingdoms of animals, plants, prokaryotes and protists. Fungi have solid cell walls and true nuclei, do not contain chlorophyll, are heterotrophic, live in a parasitic or saprophytic manner, and typically reproduce both sexually and asexually, producing spores of various forms. According to the growth characteristics and morphological di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61K36/89A61P31/10A61K33/18A61K31/60A61K31/59A61K31/58A61K31/573A61K31/496A61K31/4174A61K31/355A61K31/192A61K31/19A61K31/047
CPCA61K9/0014A61K31/047A61K31/19A61K31/192A61K31/355A61K31/4174A61K31/496A61K31/573A61K31/58A61K31/59A61K31/60A61K33/18A61K36/14A61K36/185A61K36/234A61K36/282A61K36/355A61K36/534A61K36/739A61K36/886A61K36/89A61K36/896A61K2236/331A61K2236/39A61K2236/51A61P31/10A61K2300/00
Inventor 吴红荣
Owner 吴红荣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com